Sponsor of the Day:
Jerkmate
https://recovercovid.org/publications/design-and-rationale-recover-autonomic-randomized-platform-trial-evaluating
Design and rationale of RECOVER-AUTONOMIC: a randomized platform trial evaluating interventions for...
Background: Post‑acute sequelae of SARS‑CoV‑2 infection (Long COVID) affect a substantial proportion of individuals, and among the many reported symptom
recover autonomicplatform trialdesignrationalerandomized
https://recovercovid.org/news/first-results-recover-autonomic-clinical-trials-be-shared-upcoming-conference
First results from RECOVER-AUTONOMIC clinical trials to be shared at upcoming conference | RECOVER...
Results from the RECOVER-AUTONOMIC Moderate POTS (Ivabradine) clinical trial will be presented at an upcoming session of the American College of Cardiology
first resultsrecover autonomicclinical trialsupcoming conferenceshared
https://www.radcliffecardiology.com/video-index/acc-26-recover-autonomic-ivabradine-post-covid-pots?language_content_entity=en
Ivabradine for Post-COVID POTS: RECOVER-Autonomic Insights | Radcliffe Cardiology
Discover the impact of ivabradine on orthostatic intolerance in post-COVID POTS patients based on findings from the RECOVER-Autonomic trial.
post covidrecover autonomicradcliffe cardiologypotsinsights
https://recovercovid.org/news/recover-autonomic-clinical-trial-results-shared-2026-acc-conference
RECOVER-AUTONOMIC clinical trial results shared at 2026 ACC Conference | RECOVER COVID Initiative
The RECOVER-AUTONOMIC (Ivabradine) clinical trial tested whether ivabradine, an oral medication used to lower heart rate, could be used to manage a Long COVID
clinical trial resultsrecover autonomic2026 acccovid initiativeshared
https://trials.recovercovid.org/autonomic
RECOVER Clinical Trials | AUTONOMIC
recover clinical trialsautonomic